« "Review: Thinking, Fast and Slow by Daniel Kahneman" |
| "Neuroscience Meets Cryptography" with Manchurian Candidate Undertones »
Shirley S. Wang writes in the WSJ about impressive but small-sample-size research using intravenous immunoglobulin therapy to treat Alzheimer's disease.
Posted by Adam Kolber on 07/18/2012 at 02:31 PM | Permalink
The comments to this entry are closed.